Autoimmune targets of heart and skeletal muscles in myasthenia gravis

Archives of Neurology

Volumn 66, Issue 11, 2009, Pages 1334-1338

  Suzuki, Shigeaki ^a   Utsugisawa, Kimiaki ^b   Yoshikawa, Hiroaki ^c   Motomura, Masakatsu ^d   Matsubara, Shiro ^e   Yokoyama, Kazumasa ^f   Nagane, Yuriko ^b   Maruta, Takahiro ^g   Satoh, Takashi ^a   Sato, Hideki ^a   Kuwana, Masataka ^a   Suzuki, Norihiro ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Hanamaki General Hospital   (Japan)

^c KANAZAWA UNIVERSITY   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

^e TOKYO METROPOLITAN NEUROLOGICAL HOSPITAL   (Japan)

^f JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g Keiju Medical Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CONNECTIN; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; POTASSIUM CHANNEL KV1.4; RYANODINE RECEPTOR; TACROLIMUS;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; CD8+ T LYMPHOCYTE; CELL INFILTRATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; MALE; MICROEMULSION; MYASTHENIA GRAVIS; MYOSITIS; PLASMAPHERESIS; PRIORITY JOURNAL; SEROLOGY; SKELETAL MUSCLE;

ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; MYOCARDITIS; MYOCARDIUM; MYOSITIS; THYMOMA; THYMUS NEOPLASMS;

EID: 70449650324     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2009.229     Document Type: Article

References (27)

1. Drachman DB. Myasthenia gravis. N Engl J Med. 1994;330(25):1797-1810.
2. Aarli JA. Inflammatory myopathy in myasthenia gravis. Curr Opin Neurol. 1998; 11(3):233-234.
3. Nakano S, Engel AG. Myasthenia gravis: quantitative immunocytochemical analysis of inflammatory cells and detection of complement membrane attack complex at the end-plate in 30 patients. Neurology. 1993;43(6):1167-1172. (Pubitemid 23177718)
4. Zamecnik J, Vesely D, Jakubicka B, et al. Muscle lymphocytic infiltrates in thymomaassociated myasthenia gravis are phenotypically different from those in polymyositis. Neuromuscul Disord. 2007;17(11-12):935-942. (Pubitemid 350137728)
5. Namba T, Brunner NG, Grob D. Idiopathic giant cell polymyositis: report of a case and review of the syndrome. Arch Neurol. 1974;31(1):27-30.
6. Pascuzzi RM, Roos KL, Phillips LH II. Granulomatous inflammatory myopathy associated with myasthenia gravis: a case report and review of the literature. Arch Neurol. 1986;43(6):621-623.
7. de Jongste MJ, Oosterhuis HJ, Lie KI. Intractable ventricular tachycardia in a patient with giant cell myocarditis, thymoma and myasthenia gravis. Int J Cardiol. 1986;13(3):374-378.
8. Hofstad H, Ohm OJ, Mork SJ, Aarli JA. Heart disease in myasthenia gravis. Acta Neurol Scand. 1984;70(3):176-184.
9. Romi F, Skeie GO, Gilhus NE, Aarli JA. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance. Arch Neurol. 2005;62(3):442-446. (Pubitemid 40349480)
10. Suzuki S, Satoh T, Yasuoka H, et al. Novel autoantibodies to a voltage-gated potassium channel Kv1.4 in a severe form of myasthenia gravis. J Neuroimmunol. 2005;170(1-2):141-149. (Pubitemid 41740915)
11. Suzuki S, Utsugisawa K, Nagane Y, et al. Classification of myasthenia gravis based on autoantibody status. Arch Neurol. 2007;64(8):1121-1124. (Pubitemid 47258071)
12. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet. 2003;362(9388): 971-982.
13. Jaretzki A III, Barohn RJ, Ernstoff RM, et al; Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Myasthenia gravis: recommendations for clinical research standards. Neurology. 2000;55(1): 16-23.
14. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48(11):2485-2492. (Pubitemid 12228012)
15. Rosai J, Sobin LH. Histological Typing of Tumors of the Thymus: International Histologic Classification of Tumors. 2nd ed. New York, NY: Springer; 1999.
16. Kishimoto C, Hiraoka Y. Clinical and experimental studies in myocarditis. Curr Opin Cardiol. 1994;9(3):349-356.
17. Maruta T, Yoshikawa H, Furukawa Y, Iwase K, Yamada M. A new sandwich ELISA method to detect antibodies against native form of ryanodine receptor [abstract]. J Neuroimmunol. 2006;178(suppl 1):230.
18. Suzuki S, Satoh T, Sato S, et al. Clinical utility of anti-signal recognition particle antibody in the differential diagnosis of myopathies. Rheumatology (Oxford). 2008; 47(10):1539-1542.
19. Suzuki S, Kuwana M, Yasuoka H, Tanaka K, Fukuuchi Y, Kawakami Y. Heterogeneous immunogenetic background in Japanese adults with myasthenia gravis. J Neurol Sci. 2001;189(1-2):59-64. (Pubitemid 32776650)
20. Sato H, Iwasaki E, Nogawa S, et al. A patient with giant cell myocarditis and myositis associated with thymoma and myasthenia gravis [in Japanese]. Rinsho Shinkeigaku. 2003;43(8):496-499.
21. Evoli A, Minisci C, Di Schino C, et al. Thymoma in patients with MG: characteristics and long-term outcome. Neurology. 2002;59(12):1844-1850.
22. Mygland A, Vincent A, Newsom-Davis J, et al. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia. Arch Neurol. 2000; 57(4):527-531. (Pubitemid 30212127)
23. Katz JS, Wolfe GI, Burns DK, Bryan WW, Fleckenstein JL, Barohn RJ. Isolated neck extensor myopathy: a common cause of dropped head syndrome. Neurology. 1996;46(4):917-921.
24. Puruckherr M, Pooyan P, Dube D, Byrd RP, Roy TM. The dropped head sign: an unusual presenting feature of myasthenia gravis. Neuromuscul Disord. 2004; 14(6):378-379. (Pubitemid 38622371)
25. Rodolico C, Messina S, Toscano A, Vita G, Gaeta M. Axial myopathy in myasthenia: a misleading cause of dropped head. Muscle Nerve. 2004;29(2):329-330. (Pubitemid 38166859)
26. Tan KM, Lennon VA, Klein CJ, Boeve BF, Pittock SJ. Clinical spectrum of voltagegated potassium channel autoimmunity. Neurology. 2008;70(20):1883-1890.
27. Geschwind MD, Tan KM, Lennon VA, et al. Voltage-gated potassium channel autoimmunity mimicking Creutzfeldt-Jakob disease. Arch Neurol. 2008;65(10): 1341-1346.